Chemical Structure (Fentanyl Transdermal System 1)
Fentanyl Transdermal Patch, Extended Release
Product Images NDC 0406-9062
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Fentanyl Transdermal (NDC 0406-9062). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Specgx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (50 mcg/hr)
Fentanyl Transdermal System is a prescription-only medication used for pain management that delivers a 50 mcg/hr dose of fentanyl for 72 hours. It should only be used for severe pain that cannot be managed by other medications or therapies. The system contains 50 mcg/hr patches of fentanyl, and users should not use it if the seal on the patch is broken or if they are not tolerant to opioid medications. A Medication Guide is included with the system that users should read for important safety information. This medication is manufactured by Mallinckrodt™.*
Principal Display Panel (62.5 mcg/hr)
This is a description of Fentanyl Transdermal System, containing 62.5 mcg/hr of Fentanyl. The package includes five systems. The text warns against using this product if immediate-release opioids can treat the condition. It also cautions that the product should not be used if the seal on the pouch is broken, and it should be kept out of children's reach. To use this product, a patient must be opioid tolerant. Each transdermal system contains 6875 g of Fentanyl. The description advises reading the Fentanyl Transdermal System Medication Guide for safety information. The product is manufactured by Mallinckrodt.*
Principal Display Panel (75 mcg/hr)
This is a description for Fentanyl Transdermal System, an Rx-only medication used for pain management. It comes in a system that delivers 75 mcg/hr of fentanyl for 72 hours. Each system contains 0.25 mg of fentanyl. The medication guide should be read for important safety information. The seal on the pouch should not be broken, and it should be kept away from children.*
Principal Display Panel (100 mcg/hr)
NDC 0406-9000-76 Five (100 mcg/h) Systems of Fentanyl Transdermal System with a delivery of 100 mcg/hr for 72 hours. The system contains 110mg of Fentanyl, but should not be used for immediate-release opioids as it could lead to serious breathing problems. The product should be kept out of reach of children, and should not be used if the seal on the pouch is broken. There is a medication guide available for important safety information.*
Principal Display Panel (12 mcg/hr)
Fentanyl Transdermal System is a prescription medication that provides invivo delivery of 12 mcg/hour of fentanyl for 72 hours. It is available in a package of five transdermal systems with a strength of 12 mcg/hour. The package contains a medication guide with important safety information that should be read before use. Each transdermal system contains 1375 g of medication, and the pouch should not be used if it is broken. Fentanyl Transdermal System should only be used for pain that cannot be treated with immediate-release opioids because serious breathing problems could result. The medication should be kept out of the reach of children. The expiration date of the medication is January 2008.*
Principal Display Panel (25 mcg/hr)
Principal Display Panel (50 mcg/hr)
This is a prescription drug package containing a Fentanyl Transdermal System used for delivering 50 meg/he of fentanyl for 72 hours. The package contains five systems, each with a strength of 50 mcg/hr. The drug is usually administered to manage ongoing pain or any postoperative pain but could cause breathing problems in those not tolerant to opioids. The package comes with a warning not to use if the seal is broken and to keep out of reach of children. It also recommended to read the medication guide for important safety information. The package is produced by Mallinckrodt.*
Principal Display Panel (75 mcg/hr)
This text seems to be a product description and information about usage and safety instructions for "Fentanyl Transdermal System", a medication that delivers 75 mcg/hr of fentanyl for pain over a period of 72 hours. The medication is only available with a prescription and caution needs to be exercised while using it, especially if the person is not opioid tolerant or has been using other narcotic opioid medicines. Each transdermal system contains 525 mg of fentanyl, and the seal on the pouch should not be broken. The text also includes a medication guide and important safety information.*
Principal Display Panel (100 mcg/hr)
This is a description of a prescription medication called Fentanyl Transdermal System, with a dosage of 100 mcg/hr and a 72-hour in vivo delivery. It is advised not to use it for breathing problems or for any pain that can be treated with non-opioid painkillers, intermittent pain, or post-operative pain unless the patient has previous experience with opioid medication. The package contains five 100 mcg/hr systems and each system contains 11,0 1 eniary. It is important not to use the product if the seal is broken and to keep it out of reach of children. The text includes details on the manufacturer and serial number, but it lacks some critical information such as usage instructions and possible side effects.*
Fentanyl Transdermal System Rectangular Unit (Fentanyl Transdermal System 2)
This appears to be a diagram or image with text labels representing the layers of a transdermal patch drug delivery system. It includes a backing film, rate controlling membrane, drug-containing layer, skin adhesive layer, and protective liner.*
Serum Fentanyl Concentrations (Fentanyl Transdermal System 3)
This is a table showing the serum fentanyl concentration (ng/mL) during different time intervals after the application of a fentanyl transdermal system of 100 mcg/hr. The concentration was measured for a group of 36 individuals who used the system once, and another group of 34 individuals who used it four times. The time intervals are measured in hours and go from 0 to 340 hours.*
Parts Of The Fentanyl Transdermal System (Fentanyl Transdermal System 4)
The text describes the layers of a transdermal patch that delivers a drug through the skin. The layers include a backing film, rate controlling membrane, drug-containing layer, skin adhesive layer, and a protective liner.*
Figures 1 To 8 (Fentanyl Transdermal System 5)
Images 9 And 10 (Fentanyl Transdermal System 6)
Principal Display Panel (12 mcg/hr)
Fentanyl Transdermal System is a medication used for delivering 12 mcg/hr fentanyl for 72 hours via application to the skin. It comes in the form of a transdermal system containing 1375 mg fentanyl. The medication is available in a package of five (12 mcg/hr) systems with NDC 0406-9012-76. It is only available with a prescription and is not recommended for individuals with serious or life-threatening breathing problems that can be treated by immediate-release analgesics. It is important to ensure that the seal on the pouch is not broken and to keep it out of the reach of children. For more information about the safe use of the Fentanyl Transdermal System, consult the Medication Guide.*
Principal Display Panel (25 mcg/hr)
The text is a description of a medication called Fentanyl Transdermal System in the form of five (25 mcg/hr) systems which is a prescription medication used for the treatment of pain. It is important to note that it should only be used by individuals who are opioid tolerant and not for those with breathing problems. The medication is applied through a transdermal patch which provides a 72-hour delivery of 25 meg/hr of the medication. The medication comes in a pouch which should not be used if it is broken and it should be kept away from children. The text also suggests reading the Fentanyl Transdermal System Medication Guide for important safety information.*
Principal Display Panel (37.5 mcg/hr)
This text is a medication label for Fentanyl Transdermal System used for the delivery of 37.5 mcg/hour Fentanyl for 72 hours. It contains instructions for use, warnings, dosage information, and precautions. It also reminds users to keep out of reach of children, and not to use it in case of a broken seal. It additionally provides a reference to important safety information contained in the Fentanyl Transdermal System Medication Guide.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
